Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers October 20, 2014
Pharmacy Choice - Pharmacy News - October 20, 2014

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
10/20/14 - BioDelivery Sciences to Provide BUNAVAIL Launch Update
By a News Reporter-Staff News Editor at Pharma Business Week-- BioDelivery Sciences International, Inc. will host an investor update conference call and webcast to discuss the launch of BUNAVAILâ?¢ buccal film which has been approved by the U.S. Food and Drug Administration for the maintenance treatment of opioid dependence. Since FDA approval of B
10/20/14 - Boehringer Ingelheim's OFEV Approved by FDA as a Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis [Professional Services Close - Up]
Boehringer Ingelheim Pharmaceuticals, Inc. reported that the U.S. Food and Drug Administration approved OFEV capsules for oral use for the treatment of idiopathic pulmonary fibrosis. According to a release from the Company, granted Breakthrough Therapy designation during its review by the FDA, OFEV, capsules for oral use, taken twice daily, is the
10/20/14 - FDA Approves Dexcom SHAREâ?¢, the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM)
Dexcom, Inc., a leader in continuous glucose monitoring for patients with diabetes, announced today that it has received U.S. Food and Drug Administration approval for its CGM remote mobile communications device: Dexcom SHARE. â??Dexcom SHARE represents a significant advance in diabetes care by allowing people with diabetes to share important gluco
10/20/14 - Fitch: FDA Drug Approvals Up for Breakthrough Entities, Biologics
CHICAGO& NEW YORK---- Link to Fitch Ratings' Report: Global Pharmaceutical R&D Pipeline. The number of NME approvals by the FDA during the first nine months in 2014 was up from the first nine months of 2013. The FDA cleared 33 novel medicines for U.S. marketing during the first five months of 2014, compared with 17 in 2013. The FDA has approved sev
10/20/14 - Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant
--Halozyme Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has approved new contract manufacturing facilities used in the production of Hylenex ® recombinant. The FDA approved the use of the Cook Pharmica manufacturing facility in Bloomington, Indiana for the production of bulk rHuPH20, the active ingredient used in H
10/20/14 - Medical marijuana debate focuses on what is an approved drug, and language of proposed amendment [Naples Daily News, Fla.]
Oct. 20-- NAPLES-- Voters will consider making Florida the 24th state and the first in the South to approve a comprehensive medical marijuana program, but opponents argue a synthetic form of marijuana already offers medical relief that's controlled by the Food and Drug Administration. The debate over medical marijuana in Florida has raged between s

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


The Diversion of Controlled Substances and the Law
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement